Synergetic estrogen receptor-targeting liposome nanocarriers with anti-phagocytic properties for enhanced tumor theranostics-Reference-Cited by-同舟云学术

Synergetic estrogen receptor-targeting liposome nanocarriers with anti-phagocytic properties for enhanced tumor theranostics

Published:2019 Issue:7 Volume:7 Page:1056-1063
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Wang Yuehua¹²³⁴⁵,Wang Zihua⁶⁷⁸⁹⁵,Qian Yixia¹⁰¹¹¹²¹³⁹,Fan Linyang¹⁰¹¹¹²¹³⁹,Yue Chunyan¹⁰¹¹¹²¹³⁹,Jia Fei¹⁰¹¹¹²¹³⁹,Sun Jian¹²³⁴⁵,Hu Zhiyuan¹⁰¹¹¹²¹³⁹,Wang Weizhi¹⁰¹¹¹²¹³⁹^ORCID

Affiliation:

1. School of Pharmaceutical Science and Technology

2. Health Science Platform

3. Tianjin University

4. Tianjin 300072

5. China

6. CAS Key Laboratory of Colloid

7. Interface and Chemical Thermodynamics

8. Institute of Chemistry Chinese Academy of Sciences

9. Beijing 100190

10. CAS Key Laboratory of Standardization and Measurement for Nanotechnology

11. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety

12. CAS Center for Excellence in Nanoscience

13. National Center for Nanoscience and Technology of China

Abstract

A synergetic targeted liposomal system which functionalized with both a tumor identification ligand and an immune targeting ligand was constructed. It could recognize and bind ER-positive breast cancer tissues in a specific way and reduce the macrophage phagocytosis of the nanoparticles.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Youth Innovation Promotion Association of the Chinese Academy of Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2019/TB/C8TB03351J

Reference49 articles.

1. A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer